Kerry Blanchard

Hematology Oncology
Lilly Corporate Ctr
Bldg 48/2
Indianapolis, IN 46285

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models.

A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models.

Journal: Molecular cancer therapeutics
Published: March 27, 2015
Showing 1-1 of 1

Last Updated: 09/26/2026